Shares Outstanding Shares Outstanding n/a Close	2.54M
Shares Change (YoY) Shares Change (YoY) n/a Close	1.66%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	0%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	34.51%
Shares Floating Shares Floating n/a Close	1.84M
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	26
FTD / Avg. Volume FTD / Avg. Volume n/a Close	0.19%

Short Selling Information

The latest short interest is 45.72K, so 0% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	45.72K
Short % of Shares Out Short % of Shares Out n/a Close	n/a
Short % of Float Short % of Float n/a Close	n/a
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	6.84

Valuation Ratios

The PE ratio is -0.35 and the forward PE ratio is -0.9. Singular Genomics Systems's PEG ratio is -0.07.

PE Ratio PE Ratio n/a Close	-0.35
Forward PE Forward PE n/a Close	-0.9
PS Ratio PS Ratio n/a Close	11.5
Forward PS Forward PS n/a Close	1.6
PB Ratio PB Ratio n/a Close	0.19
P/FCF Ratio P/FCF Ratio n/a Close	-0.45
PEG Ratio PEG Ratio n/a Close	-0.07

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Singular Genomics Systems.

EV / Sales EV / Sales n/a Close	n/a
EV / EBITDA EV / EBITDA n/a Close	n/a
EV / EBIT EV / EBIT n/a Close	n/a
EV / FCF EV / FCF n/a Close	n/a

Financial Position

The company has a current ratio of 10.51, with a Debt / Equity ratio of 0.42.

Current Ratio Current Ratio n/a Close	10.51
Quick Ratio Quick Ratio n/a Close	9.77
Debt / Equity Debt / Equity n/a Close	0.42
Debt / EBITDA Debt / EBITDA n/a Close	-0.87
Debt / FCF Debt / FCF n/a Close	-1.01
Interest Coverage Interest Coverage n/a Close	-93.37

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity Return on Equity n/a Close	n/a
Return on Assets Return on Assets n/a Close	n/a
Return on Invested Capital Return on Invested Capital n/a Close	n/a
Revenue Per Employee Revenue Per Employee n/a Close	$11,415.69
Profits Per Employee Profits Per Employee n/a Close	$-371,843.14
Employee Count Employee Count n/a Close	255
Asset Turnover Asset Turnover n/a Close	0.01
Inventory Turnover Inventory Turnover n/a Close	0.26

Taxes

Income Tax Income Tax n/a Close	n/a
Effective Tax Rate Effective Tax Rate n/a Close	0%

Stock Price Statistics

The stock price has increased by 137.93% in the last 52 weeks. The beta is 1.83, so Singular Genomics Systems's price volatility has been higher than the market average.

Beta Beta n/a Close	1.83
52-Week Price Change 52-Week Price Change n/a Close	137.93%
50-Day Moving Average 50-Day Moving Average n/a Close	19.81
200-Day Moving Average 200-Day Moving Average n/a Close	14.23
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	56.73
Average Volume (20 Days) Average Volume (20 Days) n/a Close	13,411

Income Statement

In the last 12 months, Singular Genomics Systems had revenue of 2.91M and earned -94.82M in profits. Earnings per share was -39.08.

Revenue Revenue n/a Close	2.91M
Gross Profit Gross Profit n/a Close	-558K
Operating Income Operating Income n/a Close	-102.8M
Net Income Net Income n/a Close	-94.82M
EBITDA EBITDA n/a Close	-86.5M
EBIT EBIT n/a Close	-93.72M
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	-39.08

Full Income Statement

Balance Sheet

The company has 16.23M in cash and 75.29M in debt, giving a net cash position of -59.05M.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	16.23M
Total Debt Total Debt n/a Close	75.29M
Net Cash Net Cash n/a Close	-59.05M
Retained Earnings Retained Earnings n/a Close	-337.6M
Total Assets Total Assets n/a Close	186.55M
Working Capital Working Capital n/a Close	112.2M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -73.65M and capital expenditures -970K, giving a free cash flow of -74.62M.

Operating Cash Flow Operating Cash Flow n/a Close	-73.65M
Capital Expenditures Capital Expenditures n/a Close	-970K
Free Cash Flow Free Cash Flow n/a Close	-74.62M
FCF Per Share FCF Per Share n/a Close	-30.75

Full Cash Flow Statement

Margins

Gross margin is -19.17%, with operating and profit margins of -3531.47% and -3257.3%.

Gross Margin Gross Margin n/a Close	-19.17%
Operating Margin Operating Margin n/a Close	-3531.47%
Pretax Margin Pretax Margin n/a Close	-3257.3%
Profit Margin Profit Margin n/a Close	-3257.3%
EBITDA Margin EBITDA Margin n/a Close	-2971.35%
EBIT Margin EBIT Margin n/a Close	-3531.47%
FCF Margin FCF Margin n/a Close	-2563.28%

Dividends & Yields

OMIC does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	n/a
FCF Yield FCF Yield n/a Close	n/a

Dividend Details

Analyst Forecast

The average price target for OMIC is $6.5, which is -67.5% lower than the current price. The consensus rating is "Hold".

Price Target Price Target n/a Close	$6.5
Price Target Difference Price Target Difference n/a Close	-67.5%
Analyst Consensus Analyst Consensus n/a Close	Hold
Analyst Count Analyst Count n/a Close	1

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	n/a
Lynch Upside Lynch Upside n/a Close	n/a
Graham Number Graham Number n/a Close	n/a
Graham Upside Graham Upside n/a Close	n/a

Stock Splits

The last stock split was on Jun 26, 2024. It was a backward split with a ratio of 1:30.

Last Split Date Last Split Date n/a Close	Jun 26, 2024
Split Type Split Type n/a Close	backward
Split Ratio Split Ratio n/a Close	1:30

Scores

Altman Z-Score Altman Z-Score n/a Close	-3.3
Piotroski F-Score Piotroski F-Score n/a Close	3